In this study, the concentrations of all members of the IL-1 family were analyzed for the first time in the serum and peritoneal fluid of women with ovarian cancer (study group) and in the serum of women with benign ovarian tumors (reference group). Here, IL1B is linked to ovarian benign neoplasm.